Risk factors for chronic kidney disease in Japan: a community-based study

Norimichi Takamatsu1, Hideharu Abe, Tatsuya Tominaga

  • 1Department of Clinical Biology and Medicine, Graduate School of Medicine, Institute of Health-Bio-Science, University of Tokushima, Tokushima, Japan. takamatu@clin.med.tokushima-u.ac.jp

BMC Nephrology
|October 29, 2009
PubMed

Insights

Urinary albumin creatinine ratio (ACR) is linked to chronic kidney disease (CKD) in younger adults, but not in older adults. This finding highlights potential age-related differences in CKD risk factors.

Area of Science:

  • Nephrology
  • Epidemiology
  • Biomarker Research

Background:

  • Chronic kidney disease (CKD) is a growing concern, predicting both end-stage renal disease and cardiovascular disease.
  • Early identification of CKD risk factors is crucial for timely intervention and management.

Purpose of the Study:

  • To evaluate biomarkers for identifying associated factors of CKD in a Japanese community.
  • To investigate age-specific associations between biomarkers and reduced kidney function.

Main Methods:

  • A cross-sectional study of 1554 individuals was conducted.
  • Kidney function was assessed using estimated glomerular filtration rate (eGFR) calculated by the Modification of Diet in Renal Disease equation.
  • Urinary albumin creatinine ratio (ACR) and urinary type IV collagen creatinine ratio were measured.

Main Results:

  • In participants younger than 65, higher ACR and hyperlipidemia were significantly associated with low eGFR.
  • In participants aged 65 and older, gender, hypertension, and hyperlipidemia were associated with low eGFR.
  • Urinary type IV collagen creatinine ratio did not show a significant association with low eGFR in either age group.

Conclusions:

  • Urinary albumin creatinine ratio (ACR) is a significant associated factor for CKD in younger individuals.
  • ACR was not found to be associated with CKD in older individuals in this study population.
  • These findings suggest age-dependent associations between biomarkers and chronic kidney disease.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...